[
  {
    "ts": null,
    "headline": "Citi Lifts Johnson & Johnson (JNJ) Price Target to $200 on MedTech Strength",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of the top stocks to buy and hold forever. Founded in 1887, the company has built a global brand and a portfolio of patent-protected drugs in oncology, immunology, neuroscience, and infectious diseases. Combined with its strong distribution network, these factors provide Johnson & Johnson (NYSE:JNJ) with a durable competitive advantage and […]",
    "url": "https://finnhub.io/api/news?id=e564a2dff833fd68460ffe98dd586db5fdc044d05085c83a4eeae35505c28ba5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756266835,
      "headline": "Citi Lifts Johnson & Johnson (JNJ) Price Target to $200 on MedTech Strength",
      "id": 136535015,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the top stocks to buy and hold forever. Founded in 1887, the company has built a global brand and a portfolio of patent-protected drugs in oncology, immunology, neuroscience, and infectious diseases. Combined with its strong distribution network, these factors provide Johnson & Johnson (NYSE:JNJ) with a durable competitive advantage and […]",
      "url": "https://finnhub.io/api/news?id=e564a2dff833fd68460ffe98dd586db5fdc044d05085c83a4eeae35505c28ba5"
    }
  }
]